Bloomberg Businessweek cover image

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

Bloomberg Businessweek

00:00

Innovations in Diabetes and Weight Loss Treatments

This chapter explores the motivations behind pharmaceutical companies' innovations in drug delivery, focusing on the transition from injections to pill forms for weight loss and diabetes treatments. It discusses the competitive landscape among major companies and examines potential future applications for these new drug forms.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner